RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib plus Capecitabine with Placebo plus Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer
Baselga, José, Zamagni, Claudio, Gómez, Patricia, Bermejo, Begoña, Nagai, Shigenori E., Melichar, Bohuslav, Chan, Arlene, Mángel, Lászlo, Bergh, Jonas, Costa, Frederico, Gómez, Henry L., Gradishar, WiLanguage:
english
Journal:
Clinical Breast Cancer
DOI:
10.1016/j.clbc.2017.05.006
Date:
May, 2017
File:
PDF, 1.14 MB
english, 2017